Top Markets
#1 Siren Siren +38.80%
#2 RedStone RedStone +24.34%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Ocean Protocol Ocean Protocol +15.45%
#5 KUB Coin KUB Coin +14.83%
#6 Perle Perle +12.11%
#7 Nosana Nosana +10.27%
#8 Wiki Cat Wiki Cat +9.55%
#9 Nockchain Nockchain +8.82%
#10 Arowana Arowana +8.55%
Coin of the day
Siren Siren
설정
언어
한국어
통화
USD
테마
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
주식 순위 #32150
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
주가
$1.49
마지막 동기화: 2026-08-17
시가총액
$10.94M
변동 (1일)
4.58%
변동 (1년)
-55.67%
국가
US
거래 Ainos, Inc. (AIMD)

카테고리

Healthcare
Ainos, Inc. (AIMD)의 수익
2026 기준 수익 TTM: 0
Ainos, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Ainos, Inc.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR